Even Though there is promising news about vaccines, and Pfizer has announced a vaccine that is 90% effective, scientist say what the vaccine is effective against is going to matter a lot for the timeline of the pandemic.
The drug maker Pfizer said on Wednesday that its coronavirus vaccine had no serious side effects, the first step of complete results from a late stage vaccine trial. The data showed that the vaccine prevented mild and servere forms of COVID-19
Pfizer’s COVID-19 vaccine needs to be stored at minus 94 degrees Fahrenheit. A Swedish company is working on a powdered vaccine that wouldn’t need refrigeration at all.
The very first doses of any approved COVID-19 vaccine should go to both front-line health care workers and residents of long-term care facilities, a committee of expert advisers for the Centers for Disease Control and Prevention recommended in an emergency meeting Tuesday evening.
It appears science may have found the Covid-19 pandemic’s off-ramp, but if we’re not careful, we could fail to take full advantage of it. This article discusses what could go wrong and how to prevent it.
The most compelling argument against human challenge trials for a COVID-19 vaccine, though, is that it might not actually be any faster. In order to infect people with the virus, we have to have a tested viral dose — one that is strong enough to infect people, but not so strong it gives an infection worse than natural spread — which can take up to a year to develop, according to Weijer.
Seventy-six wealthy nations are now committed to joining a global COVID-19 vaccine allocation plan co-led by the World Health Organization (WHO) that aims to help buy and fairly distribute the shots, the project’s co-lead said on Wednesday.
The fastest vaccine ever developed was four years. With billions of dollars invested so far fast tracking the development of the vaccine, it has allowed the vaccine makers produce doses, before knowing of the vaccine works. The idea is that if a vaccine is shown to be protective, use of it can start immediately.
A rundown of the science that goes into the decision-making process and what it tells us about when results could be available.
A University of Oxford group and the British-Swedish pharmaceutical company AstraZeneca reported Monday that their coronavirus vaccine candidate, on which the U.S. and European governments have placed substantial bets, was shown in early-stage human trials to be safe and to stimulate a strong immune response.